Experimental Ebola drugs needed for 'up to 30,000 people'

Aug 21, 2014

Experimental Ebola drugs needed for 'up to 30,000 people'

Up to 30,000 people could have used experimental treatments or vaccines so far in the world’s worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday. The calculation highlights the dilemma facing officials considering how to distribute the tiny quantities of ...

Jul 25, 2014

GSK corruption allegations spread to Syria

GlaxoSmithKline faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower’s email reviewed by Reuters. Britain’s biggest drugmaker said Thursday it was investigating the latest claims ...

Dec 12, 2013

Japan panel misled over cervical cancer vaccine decision

An article about the cervical cancer vaccine Cervarix that was used by a health ministry panel to justify subsidies for the drug was written by an employee of its manufacturer, GlaxoSmithKline K.K., informed sources said. According to the Japanese unit of Britain’s GlaxoSmithKline PLC, ...

Takeda breaks tradition with outsider at helm

Dec 4, 2013

Takeda breaks tradition with outsider at helm

by Kanoko Matsuyama

Takeda Pharmaceutical Co., the more than 230-year-old drugmaker, is starting to make a practice of breaking with tradition. The firm last week named Christophe Weber, a French national who has never worked at Takeda, as chief operating officer and the planned successor to CEO ...